Literature DB >> 8118685

Evidence for GABAergic projections from the tegmental nuclei of Gudden to the mammillary body in the rat.

D Wirtshafter1, T R Stratford.   

Abstract

Immunochemical studies have demonstrated the presence of large numbers of cells immunoreactive for glutamic acid decarboxylase (GAD) within the dorsal and ventral tegmental nuclei of Gudden. Following injections of Fluoro-Gold into the medial mammillary nucleus, a substantial proportion of the retrogradely labeled neurons within the ventral tegmental nucleus displayed GAD-like immunoreactivity. Conversely, electrolytic or excitotoxic lesions of the ventral tegmental nucleus produced a large decrease in the number of fibers and terminals immunoreactive for GAD within the medial mammillary nucleus. In contrast, electrolytic lesions of the dorsal tegmental nucleus were found to produce a large decrease in GAD-like immunoreactivity which was restricted to the lateral mammillary nucleus. Control lesions placed caudal to the dorsal tegmental nucleus were without effect. These findings suggest that the dorsal and ventral nuclei send a substantial, topographically organized, GABAeregic input to the mammillary body.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8118685     DOI: 10.1016/0006-8993(93)90656-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Neural correlates for angular head velocity in the rat dorsal tegmental nucleus.

Authors:  J P Bassett; J S Taube
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

2.  Projections from Gudden's tegmental nuclei to the mammillary body region in the cynomolgus monkey (Macaca fascicularis).

Authors:  Richard C Saunders; Seralynne D Vann; John P Aggleton
Journal:  J Comp Neurol       Date:  2012-04-15       Impact factor: 3.215

3.  A continuous attractor network model without recurrent excitation: maintenance and integration in the head direction cell system.

Authors:  Christian Boucheny; Nicolas Brunel; Angelo Arleo
Journal:  J Comput Neurosci       Date:  2005 Mar-Apr       Impact factor: 1.621

4.  Forebrain GABAergic projections from the dorsal raphe nucleus identified by using GAD67-GFP knock-in mice.

Authors:  Sun Jung Bang; Kathryn G Commons
Journal:  J Comp Neurol       Date:  2012-12-15       Impact factor: 3.215

5.  Polysynaptic pathways from the vestibular nuclei to the lateral mammillary nucleus of the rat: substrates for vestibular input to head direction cells.

Authors:  J E Brown; J P Card; B J Yates
Journal:  Exp Brain Res       Date:  2004-11-03       Impact factor: 1.972

6.  Lesions of the dorsal tegmental nuclei disrupt control of navigation by distal landmarks in cued, directional, and place variants of the Morris water task.

Authors:  Benjamin J Clark; James P Rice; Katherine G Akers; Felicha T Candelaria-Cook; Jeffrey S Taube; Derek A Hamilton
Journal:  Behav Neurosci       Date:  2013-06-03       Impact factor: 1.912

Review 7.  Time to put the mammillothalamic pathway into context.

Authors:  Christopher M Dillingham; Michal M Milczarek; James C Perry; Seralynne D Vann
Journal:  Neurosci Biobehav Rev       Date:  2020-12-09       Impact factor: 8.989

8.  Vestibular and attractor network basis of the head direction cell signal in subcortical circuits.

Authors:  Benjamin J Clark; Jeffrey S Taube
Journal:  Front Neural Circuits       Date:  2012-03-20       Impact factor: 3.492

Review 9.  Turning a Negative into a Positive: Ascending GABAergic Control of Cortical Activation and Arousal.

Authors:  Ritchie E Brown; James T McKenna
Journal:  Front Neurol       Date:  2015-06-11       Impact factor: 4.003

10.  Calcium-binding protein immunoreactivity in Gudden's tegmental nuclei and the hippocampal formation: differential co-localization in neurons projecting to the mammillary bodies.

Authors:  Christopher M Dillingham; Joshua D Holmes; Nicholas F Wright; Jonathan T Erichsen; John P Aggleton; Seralynne D Vann
Journal:  Front Neuroanat       Date:  2015-08-04       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.